GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » FFO

ImmuPharma (LSE:IMM) FFO


View and export this data going back to 2003. Start your Free Trial

What is ImmuPharma FFO?

FFO (Funds from operations) only applies to REITs.


ImmuPharma (LSE:IMM) Business Description

Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus and a life-threatening autoimmune disease.